Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael J Burke. (2014) Profile of imatinib in pediatric leukemia. Pediatric Health, Medicine and Therapeutics 5, pages 1-7.
Read now
Read now
Articles from other publishers (16)
Hsi-Che Liu, Ming-Chung Kuo, Kang-Hsi Wu, Tsai-Yun Chen, Jiann-Shiuh Chen, Ming-Chung Wang, Tung-Liang Lin, YoungSen Yang, Ming-Chun Ma, Po-Nan Wang, Jiunn-Ming Sheen, Shih-Chung Wang, Shih-Hsiang Chen, Tang-Her Jaing, Chao-Neng Cheng, Ting-Chi Yeh, Tung-Huei Lin & Lee-Yung Shih. (2023) Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan. British Journal of Cancer 128:7, pages 1294-1300.
Crossref
Crossref
Ioannis Kyriakidis, Elpis Mantadakis, Eftichia Stiakaki, Andreas H. Groll & Athanasios Tragiannidis. (2022) Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. Cancers 14:20, pages 5022.
Crossref
Crossref
Yuli Cai, Chao Liu, Ye Guo, Xiaojuan Chen, Li Zhang, Yumei Chen, Yao Zou, Wenyu Yang & Xiaofan Zhu. (2021) Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China. International Journal of Hematology 113:3, pages 413-421.
Crossref
Crossref
Shuvadeep Ganguly, Deepam Pushpam, Agrima Mian, Anita Chopra, Ritu Gupta & Sameer Bakhshi. (2020) Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India. Clinical Lymphoma Myeloma and Leukemia 20:7, pages e437-e444.
Crossref
Crossref
Deepam Pushpam & Sameer Bakhshi. (2019) Paediatric chronic myeloid leukaemia: Is it really a different disease?. Indian Journal of Medical Research 149:5, pages 600.
Crossref
Crossref
Meinolf Suttorp, Philipp Schulze, Ingmar Glauche, Gudrun Göhring, Nils von Neuhoff, Markus Metzler, Petr Sedlacek, Eveline S. J. M. de Bont, Adriana Balduzzi, Birgitte Lausen, Olga Aleinikova, Sabina Sufliarska, Günter Henze, Gabriele Strauss, Angelika Eggert, Bernhard Kremens, Andreas H. Groll, Frank Berthold, Christoph Klein, Ute Groß-Wieltsch, Karl Walter Sykora, Arndt Borkhardt, Andreas E. Kulozik, Martin Schrappe, Christina Nowasz, Manuela Krumbholz, Josephine T. Tauer, Alexander Claviez, Jochen Harbott, Hans H. Kreipe, Brigitte Schlegelberger & Christian Thiede. (2018) Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia 32:7, pages 1657-1669.
Crossref
Crossref
Anita Tahlan, Neelam Varma, Shano Naseem, Deepak Bansal, Jogeshwar Binota, Anil Sood, Man Updesh Singh Sachdeva, Pankaj Malhotra & Subhash Varma. (2017) Comparative Study of Clinico-hematological Features, Molecular Spectrum and Response to Imatinib in Chronic Myelogenous Leukemia Patients: Pediatric and Adolescent Versus Adults. Indian Journal of Hematology and Blood Transfusion 34:1, pages 19-24.
Crossref
Crossref
Jose Francis, Biswajit Dubashi, Rajan Sundaram, Suresh Chandra Pradhan & Adithan Chandrasekaran. (2015) A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients. Cancer Chemotherapy and Pharmacology 76:6, pages 1185-1189.
Crossref
Crossref
Jose Francis, Biswajit Dubashi, Rajan Sundaram, Suresh Chandra Pradhan & Adithan Chandrasekaran. (2015) Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib. Medical Oncology 32:8.
Crossref
Crossref
David Gurrea Salas, Ingmar Glauche, Josephine T. Tauer, Christian Thiede & Meinolf Suttorp. (2015) Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?. Annals of Hematology 94:8, pages 1363-1371.
Crossref
Crossref
Viswanath Reddy Belum, Courtney Washington, Christine A. Pratilas, Vincent Sibaud, Franck Boralevi & Mario E. Lacouture. (2015) Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis. Pediatric Blood & Cancer 62:5, pages 798-806.
Crossref
Crossref
. (2015) Imatinib. Reactions Weekly 1535:1, pages 131-131.
Crossref
Crossref
L. Farzin, M. E. Moassesi, F. Sajadi & M. A. Ahmadi Faghih. (2014) A case-control study on serum antioxidants status (Se, Zn, and Cu) in children with chronic myeloid leukemia. International Journal of Laboratory Hematology 36:4, pages e34-e36.
Crossref
Crossref
X-D Mo, Q Jiang, L-P Xu, D-H Liu, K-Y Liu, B Jiang, H Jiang, H Chen, Y-H Chen, X-H Zhang, W Han, Y Wang & X-J Huang. (2014) Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib. Bone Marrow Transplantation 49:4, pages 576-580.
Crossref
Crossref
Naveen Pemmaraju & Jorge Cortes. (2014) Chronic Myeloid Leukemia in Adolescents and Young Adults: Patient Characteristics, Outcomes and Review of the Literature. Acta Haematologica 132:3-4, pages 298-306.
Crossref
Crossref
Hyun Jin OhMun Sung ChoJae Wook LeePil-Sang JangNack-Gyun ChungBin ChoHack-Ki Kim. (2013) Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia. Korean Journal of Pediatrics 56:8, pages 343.
Crossref
Crossref